News
Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback